Common use of Warrant Exercise Log Clause in Contracts

Warrant Exercise Log. Date Number of Warrant Shares Available to be Exercised Number of Warrant Shares Exercised Number of Warrant Shares Remaining to be Exercised AINOS, INC. WARRANT DATED __________, 2022 WARRANT NO. [ ] FORM OF ASSIGNMENT [To be completed and signed only upon transfer of Warrant] FOR VALUE RECEIVED, the undersigned hereby sells, assigns and transfers unto ________________________________ the right represented by the above-captioned Warrant to purchase ____________ shares of Company Common Stock and appoints ________________ attorney to transfer said right on the books of the Company with full power of substitution in the premises. Dated: _______________, ____ (Signature must conform in all respects to name of holder as specified on the face of the Warrant) Address of Transferee In the presence of: __________________________ ANNEX VI FORM OF PRESS RELEASE AINOS, INC. __________, 2022 Ainos, Inc. (the “Company”) announced today that Maxim Group LLC, the sole book-running manager in the Company’s recent public sale of _____ shares of Common Stock, are [waiving][releasing] a lock-up restriction with respect to ____ shares of Common Stock held by [certain officers or directors] [an officer or director] of the Company. The [waiver][release] will take effect on ____, 2022 and the shares of Common Stock may be sold on or after such date. This press release is not an offer for sale of the securities in the United States or in any other jurisdiction where such offer is prohibited, and such securities may not be offered or sold in the United States absent registration or an exemption from registration under the United States Securities Act of 1933, as amended.

Warrant Exercise Log. Date Number of Warrant Shares Available to be Exercised Number of Warrant Shares Exercised Number of Warrant Shares Remaining to be Exercised AINOS, INC. RYDE GROUP LTD WARRANT DATED __________, 2022 2023 WARRANT NO. [ ] Annex V-18 FORM OF ASSIGNMENT [To be completed and signed only upon transfer of Warrant] FOR VALUE RECEIVED, the undersigned hereby sells, assigns and transfers unto ________________________________ the right represented by the above-captioned Warrant to purchase ____________ shares of Company Common Stock Class A Ordinary Shares and appoints ________________ attorney to transfer said right on the books of the Company with full power of substitution in the premises. Dated: _______________, ____ (Signature must conform in all respects to name of holder as specified on the face of the Warrant) Address of Transferee In the presence of: __________________________ Annex V-19 ANNEX VI FORM OF PRESS RELEASE AINOS, INC. Ryde Group Ltd __________, 2022 Ainos, Inc. 2023 Ryde Group Ltd (the “Company”) announced today that Maxim Group LLC, the sole book-running manager in the Company’s recent public sale of _____ Class A ordinary shares of Common Stock(“Ordinary Shares”), are [waiving][releasing] a lock-up restriction with respect to ____ shares of Common Stock Ordinary Shares held by [certain officers or directors] [an officer or director] of the Company. The [waiver][release] will take effect on ____, 2022 2023 and the shares of Common Stock Ordinary Shares may be sold on or after such date. This press release is not an offer for sale of the securities in the United States or in any other jurisdiction where such offer is prohibited, and such securities may not be offered or sold in the United States absent registration or an exemption from registration under the United States Securities Act of 1933, as amended.. [to be attached]

Warrant Exercise Log. Date Number of Warrant Shares Available to be Exercised Number of Warrant Shares Exercised Number of Warrant Shares Remaining to be Exercised AINOS, SIYATA MOBILE INC. WARRANT DATED __________, 2022 202_ WARRANT NO. [ ] FORM OF ASSIGNMENT [To be completed and signed only upon transfer of Warrant] FOR VALUE RECEIVED, the undersigned hereby sells, assigns and transfers unto ________________________________ the right represented by the above-captioned Warrant to purchase ____________ shares share of Company Common Stock Shares and appoints ________________ attorney to transfer said right on the books of the Company with full power of substitution in the premises. Dated: _______________, ____ _______________________________________ (Signature must conform in all respects to name of holder as specified on the face of the Warrant) _______________________________________ Address of Transferee _______________________________________ _______________________________________ In the presence of: __________________________ ANNEX VI V FORM OF PRESS RELEASE AINOS, INC. Siyata Mobile Inc. __________, 2022 Ainos, Siyata Mobile Inc. (the “Company”) announced today that Maxim Group Partners LLC, the sole book-running manager in the Company’s recent public sale of _____ shares of Common StockShares and ___ Warrants, are [waiving][releasing] a lock-up restriction with respect to ____ shares of Common Stock Shares held by [certain officers or directors] [an officer or director] of the Company. The [waiver][release] will take effect on ____, 2022 and the shares of Common Stock Shares may be sold on or after such date. This press release is not an offer for sale of the securities in the United States or in any other jurisdiction where such offer is prohibited, and such securities may not be offered or sold in the United States absent registration or an exemption from registration under the United States Securities Act of 1933, as amended.. [to be attached]

Warrant Exercise Log. Date Number of Warrant Shares Available to be Exercised Number of Warrant Shares Exercised Number of Warrant Shares Remaining to be Exercised AINOS, INCEDIBLE GARDEN AG INCORPORATED. WARRANT DATED __________, 2022 WARRANT NO. [ ] FORM OF ASSIGNMENT [To be completed and signed only upon transfer of Warrant] FOR VALUE RECEIVED, the undersigned hereby sells, assigns and transfers unto ________________________________ the right represented by the above-captioned Warrant to purchase ____________ shares of Company Common Stock and appoints ________________ attorney to transfer said right on the books of the Company with full power of substitution in the premises. Dated: _______________, ____ (Signature must conform in all respects to name of holder as specified on the face of the Warrant) Address of Transferee In the presence of: __________________________ ANNEX VI IV FORM OF PRESS RELEASE AINOS, INC. EDIBLE GARDEN AG INCORPORATED __________, 2022 Ainos, Inc. 202_ Edible Garden AG Incorporated (the “Company”) announced today that Maxim Group LLC, the sole book-running manager in the Company’s recent public sale of _____ shares of Common Stock, are [waiving][releasing] a lock-up restriction with respect to ____ shares of Common Stock held by [certain officers or directors] [an officer or director] of the Company. The [waiver][release] will take effect on ____, 2022 202_ and the shares of Common Stock may be sold on or after such date. This press release is not an offer for sale of the securities in the United States or in any other jurisdiction where such offer is prohibited, and such securities may not be offered or sold in the United States absent registration or an exemption from registration under the United States Securities Act of 1933, as amended.

Warrant Exercise Log. Date Number of Warrant Shares Available to be Exercised Number of Warrant Shares Exercised Number of Warrant Shares Remaining to be Exercised AINOS, INC. REGENCELL BIOSCIENCE HOLDINGS LIMITED WARRANT DATED __________, 2022 2021 WARRANT NO. [ ] FORM OF ASSIGNMENT [To be completed and signed only upon transfer of Warrant] FOR VALUE RECEIVED, the undersigned hereby sells, assigns and transfers unto ________________________________ the right represented by the above-captioned Warrant to purchase ____________ shares share of Company Common Stock Ordinary Shares and appoints ________________ attorney to transfer said right on the books of the Company with full power of substitution in the premises. Dated: _______________, ____ (Signature must conform in all respects to name of holder as specified on the face of the Warrant) Address of Transferee In the presence of: __________________________ ANNEX VI FORM OF PRESS RELEASE AINOS, INCRegencell Bioscience Holdings Limited. __________, 2022 Ainos, Inc. 2021 Regencell Bioscience Holdings Limited (the “Company”) announced today that Maxim Group LLC, the sole book-running manager in the Company’s recent public sale of _____ shares of Common StockOrdinary Shares, are [waiving][releasing] a lock-up restriction with respect to ____ shares of Common Stock Ordinary Shares held by [certain officers or directors] [an officer or director] of the Company. The [waiver][release] will take effect on ____, 2022 2021 and the shares of Common Stock Ordinary Shares may be sold on or after such date. This press release is not an offer for sale of the securities in the United States or in any other jurisdiction where such offer is prohibited, and such securities may not be offered or sold in the United States absent registration or an exemption from registration under the United States Securities Act of 1933, as amended.. [to be attached]

Warrant Exercise Log. Date Number of Warrant Shares Available to be Exercised Number of Warrant Shares Exercised Number of Warrant Shares Remaining to be Exercised AINOS, INC. ARB IOT GROUP LIMITED WARRANT DATED __________, 2022 2023 WARRANT NO. [ ] FORM OF ASSIGNMENT [To be completed and signed only upon transfer of Warrant] FOR VALUE RECEIVED, the undersigned hereby sells, assigns and transfers unto ________________________________ the right represented by the above-captioned Warrant to purchase ____________ shares of Company Common Stock Ordinary Shares and appoints ________________ attorney to transfer said right on the books of the Company with full power of substitution in the premises. Dated: _______________, ____ (Signature must conform in all respects to name of holder as specified on the face of the Warrant) Address of Transferee In the presence of: __________________________ ANNEX VI FORM OF PRESS RELEASE AINOS, INCARB IOT Group Limited. __________, 2022 Ainos, Inc. 2023 ARB IOT Group Limited (the “Company”) announced today that Maxim Group LLC, the sole book-running manager in the Company’s recent public sale of _____ shares of Common StockOrdinary Shares, are [waiving][releasing] a lock-up restriction with respect to ____ shares of Common Stock Ordinary Shares held by [certain officers or directors] [an officer or director] of the Company. The [waiver][release] will take effect on ____, 2022 2023 and the shares of Common Stock Ordinary Shares may be sold on or after such date. This press release is not an offer for sale of the securities in the United States or in any other jurisdiction where such offer is prohibited, and such securities may not be offered or sold in the United States absent registration or an exemption from registration under the United States Securities Act of 1933, as amended.. [to be attached]

Warrant Exercise Log. Date Number of Warrant Shares Available to be Exercised Number of Warrant Shares Exercised Number of Warrant Shares Remaining to be Exercised AINOSCORPHOUSING GROUP, INC. WARRANT DATED __________, 2022 WARRANT NO. [ ] FORM OF ASSIGNMENT [To be completed and signed only upon transfer of Warrant] FOR VALUE RECEIVED, the undersigned hereby sells, assigns and transfers unto ________________________________ the right represented by the above-captioned Warrant to purchase ____________ shares of Company Common Stock and appoints ________________ attorney to transfer said right on the books of the Company with full power of substitution in the premises. Dated: _______________, ____ (Signature must conform in all respects to name of holder as specified on the face of the Warrant) Address of Transferee In the presence of: __________________________ ANNEX VI IV FORM OF PRESS RELEASE AINOSCORPHOUSING GROUP, INC. __________, 2022 AinosCorphousing Group, Inc. (the “Company”) announced today that Maxim Group LLC, the sole book-running manager in the Company’s recent public sale of _____ shares of Common Stock, are [waiving][releasing] a lock-up restriction with respect to ____ shares of Common Stock held by [certain officers or directors] [an officer or director] of the Company. The [waiver][release] will take effect on ____, 2022 and the shares of Common Stock may be sold on or after such date. This press release is not an offer for sale of the securities in the United States or in any other jurisdiction where such offer is prohibited, and such securities may not be offered or sold in the United States absent registration or an exemption from registration under the United States Securities Act of 1933, as amended.. [to be attached]

Warrant Exercise Log. Date Number of Warrant Shares Available to be Exercised Number of Warrant Shares Exercised Number of Warrant Shares Remaining to be Exercised AINOS, INCNLS PHARMACEUTICS LTD. WARRANT DATED __________, 2022 2021 WARRANT NO. [ ] FORM OF ASSIGNMENT [To be completed and signed only upon transfer of Warrant] FOR VALUE RECEIVED, the undersigned hereby sells, assigns and transfers unto ________________________________ the right represented by the above-captioned Warrant to purchase ____________ shares share of Company Common Stock Shares and appoints ________________ attorney to transfer said right on the books of the Company with full power of substitution in the premises. Dated: _______________, ____ (Signature must conform in all respects to name of holder as specified on the face of the Warrant) Address of Transferee In the presence of: __________________________ ANNEX VI III FORM OF PRESS RELEASE AINOS, INC. NLS Pharmaceutics Ltd. __________, 2022 Ainos, Inc. 2021 NLS Pharmaceutics Ltd. (the “Company”) announced today that Maxim Group LLC, the sole book-running manager in the Company’s recent public sale of _____ shares of Common StockShares, are is [waiving][releasing] a lock-up restriction with respect to ____ shares of Common Stock Shares held by [certain officers or directors] [an officer or director] of the Company. The [waiver][release] will take effect on ____, 2022 2020 and the shares of Common Stock Shares may be sold on or after such date. This press release is not an offer for sale of the securities in the United States or in any other jurisdiction where such offer is prohibited, and such securities may not be offered or sold in the United States absent registration or an exemption from registration under the United States Securities Act of 1933, as amended.. ANNEX IV Form of Subscription Form Referring to [(A) the resolution of the shareholders’ meeting dated [●], 2021 of NLS Pharmaceutics Ltd., with registered office in Stans, Canton of Nidwalden, Switzerland (the “Company”), which are known to the undersigned (the “Subscriber”), and according to which the Company’s share capital shall be increased by way of an ordinary capital increase in a maximum amount of CHF [●] by issuing up to [●] registered shares with a nominal value of CHF 0.02. Pursuant to such resolution, the board of directors of the Company (the “Board of Directors”) shall effectuate the capital increase within 3 months.]2 [(A) the articles of association of NLS Pharmaceutics Ltd., with registered office in Stans, Canton of Nidwalden, Switzerland (the “Company”), which are known to the undersigned (the “Subscriber”) and which authorize the board of directors of the Company (the “Board of Directors”) to effect an increase of the Company’s share capital in a maximum amount of CHF [●] by issuing up to [●] registered shares with a nominal value of CHF 0.02 each out of the Company’s authorized share capital, such authorization having been granted by resolution of the shareholders meeting of [●], 2021]3

Warrant Exercise Log. Date Number of Warrant Shares Available to be Exercised Number of Warrant Shares Exercised Number of Warrant Shares Remaining to be Exercised AINOS, INCNLS PHARMACEUTICS LTD. WARRANT DATED __________, 2022 2020 WARRANT NO. [ ] FORM OF ASSIGNMENT [To be completed and signed only upon transfer of Warrant] FOR VALUE RECEIVED, the undersigned hereby sells, assigns and transfers unto ________________________________ the right represented by the above-captioned Warrant to purchase ____________ shares share of Company Common Stock Shares and appoints ________________ attorney to transfer said right on the books of the Company with full power of substitution in the premises. Dated: _______________, ____ (Signature must conform in all respects to name of holder as specified on the face of the Warrant) Address of Transferee In the presence of: __________________________ ANNEX VI III FORM OF PRESS RELEASE AINOS, INC. NLS Pharmaceutics Ltd. __________, 2022 Ainos, Inc. 2020 NLS Pharmaceutics Ltd. (the “Company”) announced today that Maxim Group LLC, the sole book-running manager in the Company’s recent public sale of _____ shares of Common StockShares, are is [waiving][releasing] a lock-up restriction with respect to ____ shares of Common Stock Shares held by [certain officers or directors] [an officer or director] of the Company. The [waiver][release] will take effect on ____, 2022 2020 and the shares of Common Stock Shares may be sold on or after such date. This press release is not an offer for sale of the securities in the United States or in any other jurisdiction where such offer is prohibited, and such securities may not be offered or sold in the United States absent registration or an exemption from registration under the United States Securities Act of 1933, as amended.. ANNEX IV Form of Subscription Form Referring to [(A) the resolution of the shareholders’ meeting dated [●], 2020 of NLS Pharmaceutics Ltd., with registered office in Stans, Canton of Nidwalden, Switzerland (the “Company”), which are known to the undersigned (the “Subscriber”), and according to which the Company’s share capital shall be increased by way of an ordinary capital increase in a maximum amount of CHF [●] by issuing up to [●] registered shares with a nominal value of CHF 0.02. Pursuant to such resolution, the board of directors of the Company (the “Board of Directors”) shall effectuate the capital increase within 3 months.]2 [(A) the articles of association of NLS Pharmaceutics Ltd., with registered office in Stans, Canton of Nidwalden, Switzerland (the “Company”), which are known to the undersigned (the “Subscriber”) and which authorize the board of directors of the Company (the “Board of Directors”) to effect an increase of the Company’s share capital in a maximum amount of CHF [●] by issuing up to [●] registered shares with a nominal value of CHF 0.02 each out of the Company’s authorized share capital, such authorization having been granted by resolution of the shareholders meeting of [●], 2020]3

Warrant Exercise Log. Date Number of Warrant Shares Available to be Exercised Number of Warrant Shares Exercised Number of Warrant Shares Remaining to be Exercised AINOSSTAR EQUITY HOLDINGS, INC. WARRANT DATED __________, 2022 WARRANT NO. [ ] FORM OF ASSIGNMENT [To be completed and signed only upon transfer of Warrant] FOR VALUE RECEIVED, the undersigned hereby sells, assigns and transfers unto ________________________________ the right represented by the above-captioned Warrant to purchase ____________ shares share of Company Common Stock and appoints ________________ attorney to transfer said right on the books of the Company with full power of substitution in the premises. Dated: _______________, ____ _______________________________________ (Signature must conform in all respects to name of holder as specified on the face of the Warrant) _______________________________________ Address of Transferee _______________________________________ _______________________________________ In the presence of: __________________________ ANNEX VI V FORM OF PRESS RELEASE AINOSStar Equity Holdings, INC. Inc. __________, 2022 AinosStar Equity Holdings, Inc. (the “Company”) announced today that Maxim Group LLC, the sole book-running manager in the Company’s recent public sale of _____ shares of Common StockStock and ______ Pre-Funded Warrants, are [waiving][releasing] a lock-up restriction with respect to ____ shares of Common Stock the Company’s common stock held by [certain officers or directors] [an officer or director] of the Company. The [waiver][release] will take effect on ____, 2022 and the shares of Common Stock may be sold on or after such date. This press release is not an offer for sale of the securities in the United States or in any other jurisdiction where such offer is prohibited, and such securities may not be offered or sold in the United States absent registration or an exemption from registration under the United States Securities Act of 1933, as amended.. [Press release to be attached]

Warrant Exercise Log. Date Number of Warrant Shares Available to be Exercised Number of Warrant Shares Exercised Number of Warrant Shares Remaining to be Exercised AINOS, INCEDIBLE GARDEN AG INCORPORATED. WARRANT DATED __________, 2022 2023 WARRANT NO. [ ] FORM OF ASSIGNMENT [To be completed and signed only upon transfer of Warrant] FOR VALUE RECEIVED, the undersigned hereby sells, assigns and transfers unto ________________________________ the right represented by the above-captioned Warrant to purchase ____________ shares of Company Common Stock and appoints ________________ attorney to transfer said right on the books of the Company with full power of substitution in the premises. Dated: _______________, ____ (Signature must conform in all respects to name of holder as specified on the face of the Warrant) Address of Transferee In the presence of: __________________________ ANNEX VI IV FORM OF PRESS RELEASE AINOS, INC. EDIBLE GARDEN AG INCORPORATED __________, 2022 Ainos, Inc. 202_ Edible Garden AG Incorporated (the “Company”) announced today that Maxim Group LLC, the sole book-running manager in the Company’s recent public sale of _____ shares of Common Stock, are [waiving][releasing] a lock-up restriction with respect to ____ shares of Common Stock held by [certain officers or directors] [an officer or director] of the Company. The [waiver][release] will take effect on ____, 2022 202_ and the shares of Common Stock may be sold on or after such date. This press release is not an offer for sale of the securities in the United States or in any other jurisdiction where such offer is prohibited, and such securities may not be offered or sold in the United States absent registration or an exemption from registration under the United States Securities Act of 1933, as amended.

Warrant Exercise Log. Date Number of Warrant Shares Available to be Exercised Number of Warrant Shares Exercised Number of Warrant Shares Remaining to be Exercised AINOS, INCSIMPPLE LTD. WARRANT DATED __________, 2022 2023 WARRANT NO. [ ] FORM OF ASSIGNMENT [To be completed and signed only upon transfer of Warrant] FOR VALUE RECEIVED, the undersigned hereby sells, assigns and transfers unto ________________________________ the right represented by the above-captioned Warrant to purchase ____________ shares share of Company Common Stock Ordinary Shares and appoints ________________ attorney to transfer said right on the books of the Company with full power of substitution in the premises. Dated: _______________, ____ (Signature must conform in all respects to name of holder as specified on the face of the Warrant) Address of Transferee In the presence of: __________________________ ANNEX VI FORM OF PRESS RELEASE AINOS, INCSIMPPLE LTD. __________, 2022 Ainos, Inc. 2023 SIMPPLE LTD. (the “Company”) announced today that Maxim Group LLC, the sole book-running manager in the Company’s recent public sale of _____ shares of Common StockOrdinary Shares, are [waiving][releasing] a lock-up restriction with respect to ____ shares of Common Stock Ordinary Shares held by [certain officers or directors] [an officer or director] of the Company. The [waiver][release] will take effect on ____, 2022 2023 and the shares of Common Stock Ordinary Shares may be sold on or after such date. This press release is not an offer for sale of the securities in the United States or in any other jurisdiction where such offer is prohibited, and such securities may not be offered or sold in the United States absent registration or an exemption from registration under the United States Securities Act of 1933, as amended.. [to be attached]

Warrant Exercise Log. Date Number of Warrant Shares Available to be Exercised Number of Warrant Shares Exercised Number of Warrant Shares Remaining to be Exercised AINOS, INC. SOCIETY PASS INCORPORATED WARRANT DATED __________, 2022 2021 WARRANT NO. [ ] FORM OF ASSIGNMENT [To be completed and signed only upon transfer of Warrant] FOR VALUE RECEIVED, the undersigned hereby sells, assigns and transfers unto ________________________________ the right represented by the above-captioned Warrant to purchase ____________ shares of Company Common Stock and appoints ________________ attorney to transfer said right on the books of the Company with full power of substitution in the premises. Dated: _______________, ____ _______________________________________ (Signature must conform in all respects to name of holder as specified on the face of the Warrant) _______________________________________ Address of Transferee _______________________________________ _______________________________________ In the presence of: __________________________ ANNEX VI V FORM OF PRESS RELEASE AINOS, INCSociety Pass Incorporated. __________, 2022 Ainos, Inc. 2021 Society Pass Incorporated (the “Company”) announced today that Maxim Group LLC, the sole book-running manager in the Company’s recent public sale of _____ shares of Common Stock, are [waiving][releasing] a lock-up restriction with respect to ____ shares of Common Stock held by [certain officers or directors] [an officer or director] of the Company. The [waiver][release] will take effect on ____, 2022 2021 and the shares of Common Stock may be sold on or after such date. This press release is not an offer for sale of the securities in the United States or in any other jurisdiction where such offer is prohibited, and such securities may not be offered or sold in the United States absent registration or an exemption from registration under the United States Securities Act of 1933, as amended.. [to be attached]

Warrant Exercise Log. Date Number of Warrant Shares Available to be Exercised Number of Warrant Shares Exercised Number of Warrant Shares Remaining to be Exercised AINOS, INC. SOCIETY PASS INCORPORATED WARRANT DATED ___________ , 2022 2021 WARRANT NO. [ ] FORM OF ASSIGNMENT [To be completed and signed only upon transfer of Warrant] FOR VALUE RECEIVED, the undersigned hereby sells, assigns and transfers unto ________________________________ the right represented by the above-captioned Warrant to purchase ____________ shares of Company Common Stock and appoints ________________ attorney to transfer said right on the books of the Company with full power of substitution in the premises. Dated: _______________, ____ (Signature must conform in all respects to name of holder as specified on the face of the Warrant) Address of Transferee In the presence of: __________________________ ANNEX VI V FORM OF PRESS RELEASE AINOS, INCSociety Pass Incorporated. __________, 2022 Ainos, Inc. 2021 Society Pass Incorporated (the “Company”) announced today that Maxim Group LLC, the sole book-running manager in the Company’s recent public sale of _____ shares of Common Stock, are [waiving][releasing] a lock-up restriction with respect to ____ shares of Common Stock held by [certain officers or directors] [an officer or director] of the Company. The [waiver][release] will take effect on ____, 2022 2021 and the shares of Common Stock may be sold on or after such date. This press release is not an offer for sale of the securities in the United States or in any other jurisdiction where such offer is prohibited, and such securities may not be offered or sold in the United States absent registration or an exemption from registration under the United States Securities Act of 1933, as amended.. [to be attached]